Domain Summary

biocon.com

biocon is an innovation led fully integrated biopharmaceutical company that develop affordable biosimilars, generic formulations & complex apis

Biocon - India's largest biopharmaceutical company

Global rank: #359511
Daily visitors: 3.43K
Monthly Visits: 102,993
Pageviews per user: 4.76
Registrar Abuse Contact Email: [email protected]
Registrant Phone:
Rating
TLD: com
IP Address: 104.211.200.148
Organization: Microsoft Corporation
Category: Health >
Pharmacy
biocon.com Icon
biocon.com
Last Status:
Online
Last Updated: 14 day ago
loading

About Website

Click here to check amazing https biospace biocon com content for India. Otherwise, check out these important facts you probably never knew about biocon.com

biocon is an innovation led fully integrated biopharmaceutical company that develop affordable biosimilars, generic formulations & complex apis

Visit biocon.comRight Arrow
Trust Score DNS Competitors Traffic SSL HTTP Headers WHOIS Reviews SEO

biocon.com Trust Score

biocon.com is probably legit as the trust score is reasonable. Our algorithm rated biocon.com a 76. Although our rating of biocon.com is medium to low risk, we encourage you to always vote as the evaluation of the site is done automatically.

The trust rating is high. Might be safe.
Trustscore
76 / 100

What is your feeling about biocon.com?

rating 10
rating 20
rating 30
rating 40
rating 50
No reviews. Be the first to Review.

Which Sites are Alternatives & Competitors to biocon.com?

Explore the top alternatives and rivals of biocon.com in November 2024, and assess their data relating to website traffic, SEO, Web Server Information, and Whois. Refer to the list below for the best competitors of biocon.com, and simply click on each one to delve into their specific details.

Mentioned on Their Website:

  • bioconbiologicsus.com
    Biocon Biologics | Advancing Biosimilars for a Healthier and …

    https://www.bioconbiologicsus.com/

    Biocon Biologics is a global leader in the development and commercialization of biosimilars. Our cutting-edge science, extensive portfolio of biosimilars, and commitment …

  • biocon.com
    Paul Vazhayil Thomas - Chief Commercial Officer, US - Biocon

    https://www.biocon.com/businesses/biosimilars/paul-vazhayil-thomas/

    Paul Vazhayil Thomas is Global Head – Portfolio and Program Management. In this role, he leads the portfolio selection and lifecycle management process in close collaboration with the Commercial, Development, IP/ Legal, Finance and Operations teams to identify, propose and curate Biocon Biologics’ product pipeline. Paul is responsible for ...

  • biocon.com
    Biocon Q4FY24 Revenue at Rs 3,966 Cr, EBITDA at Rs 964 Cr; …

    https://www.biocon.com/biocon-q4fy24-revenue/

    Website: www.biocon.com; Follow-us on Twitter: @bioconlimited for company updates. Biocon Biologics Ltd. (BBL) , a subsidiary of Biocon Limited, is a unique, fully integrated, global biosimilars company committed to transforming healthcare and transforming lives by enabling affordable access to high quality biosimilars for millions of …

  • biocon.com
    Biocon Biologics Announces Divestment of Two Non-Core …

    https://www.biocon.com/biocon-biologics-announces-divestment-of-two-non-core-branded-formulations-india-business-units/

    Bengaluru, Karnataka, India: November 08, 2023: Biocon Biologics Limited (BBL), a subsidiary of Biocon Limited (BSE code: 532523, NSE: BIOCON), today announced that it has entered into a definitive agreement with Eris Lifesciences (Eris) for the divesture of its Dermatology and Nephrology branded formulations business units in …

  • biocon.com
    Biocon Biologics Expands Footprint in Emerging Markets Takes …

    https://www.biocon.com/biocon-biologics-expands-footprint-in-emerging-markets-takes-over-the-commercialization-of-biosimilars-business-from-viatris-in-70-countries/

    Bengaluru, Karnataka, India: July 5, 2023. Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced that the company has completed the integration of the acquired biosimilars business in over 70 countries in Emerging Markets effective July 1, 2023, increasing the scale and scope of …

  • biocon.com
    Turning clients’ ideas into meaningful innovation. - Biocon

    https://www.biocon.com/businesses/research-and-development/

    Turning clients’ ideas into meaningful innovation. Syngene is a publicly listed subsidiary whose core capabilities include highly effective problem-solving and scientific innovation, allied to a clear commitment to safety, quality, and operating excellence. It takes an integrated approach to the disciplines of discovery, development and ...

  • biocon.com
    Biocon - India's largest biopharmaceutical company

    https://www.biocon.com/docs/Biocon_Annual_Report_2021.pdf

    Biocon - India's largest biopharmaceutical company

  • zoominfo.com
    Biocon - Overview, News & Similar companies | ZoomInfo.com

    https://www.zoominfo.com/c/biocon-ltd/4735609

    Biocon contact info: Phone number: +91 8028082808 Website: www.biocon.com What does Biocon do? Established in 1978 and headquartered in Bengaluru, India, Biocon is a global biopharmaceuticals company.

  • archive.biocon.com
    Biocon's Innovative Matrix

    https://archive.biocon.com/biocon_aboutus.asp

    Biocon is a fully integrated healthcare company that delivers innovative biopharmaceutical solutions. Our drug development capabilities include biosimilars, fermentation, human …

  • biospace.biocon.com
    biospace.biocon.com

    https://biospace.biocon.com/

    Welcome. Information Security Policy : Information Assets are critical to the Success of our business. We shall therefore, Secure information assets of organization and customers, …

  • biocon.com
    Key Management Team - Biocon - Global Biopharmaceutical …

    https://www.biocon.com/about-us/management-team/

    At Biocon, the vast experience and the strategic focus of the Key Management Team steer us towards our goals. The Key Management Team focuses on driving innovative work practices and higher process maturity across the organisation. It executes its role in corporate governance through regular reviews of our financial performance and critical ...

  • bioconbiologics.com
    Contact Us - Enquiry and information regarding our businesses

    https://www.bioconbiologics.com/contact-us/

    Biocon Research Centre – Biocon Park Plot Nos. 2,3,4&5, Phase 4 – B.I.A Bommasandra-Jigani Link Road Bengaluru 560 099, Karnataka, India T +91 80 2808 2808 M Google Maps

  • archive.biocon.com
    Our Business - Biocon is an innovation-led global …

    https://archive.biocon.com/biocon_our_business.asp

    Biocon is an innovation-led global biopharmaceutical enterprise that aims to transform scientific discoveries into medical advances that can impact human health. We have …

  • biocon.com
    Subsidiary Financials of Biocon Biologics, Syngene, Biocon Pharma

    https://www.biocon.com/investor-relations/financial-information/subsidiary-financials/

    FY 2021 - 22. FY 2020 - 21. FY 2019 - 20. ARCHIVES. FY: From April 1 – March 31. Access Subsidiary Financials statements from Syngene, Biocon Pharma, Biocon Biologics, Biocon Academy, Biocon Biosphere, Biocon Healthcare...

  • archive.biocon.com
    Biocon - India's largest biopharmaceutical company

    https://archive.biocon.com/

    Biocon is an innovation led fully integrated biopharmaceutical company that has developed affordable biosimilars, novel biologics and complex APIs. Leader in fermentation based …

  • biocon.com
    Functions - Biocon - Global Biopharmaceutical company

    https://www.biocon.com/careers/functions/

    Biocon is an innovation-led global biopharmaceutical enterprise that aims to transform scientific discoveries into medical advances that impact human health. We have built differentiated capabilities based on our deep insight into Life Sciences. We have acquired the knowledge, expertise and skills essential for developing and manufacturing ...

  • biocon.com
    Novel Biologics - Enabling cutting edge therapies for cancer

    https://www.biocon.com/businesses/novel-biologics/

    Bicara Therapeutics, a clinical-stage biotechnology company based in Boston, U.S., anchors the development of a pipeline of bifunctional antibodies that exploit the recent advances in immuno-oncology. Bicara has access to the thriving innovation ecosystem in the U.S. enabling it to accelerate the development of cutting-edge therapies for cancer.

  • newsroom.viatris.com
    Viatris and Biocon Biologics Announce Launch of ... - Viatris …

    https://newsroom.viatris.com/2021-11-16-Viatris-and-Biocon-Biologics-Announce-Launch-of-Interchangeable-SEMGLEE-R-insulin-glargine-yfgn-Injection-and-Insulin-Glargine-insulin-glargine-yfgn-Injection

    PITTSBURGH and BENGALURU, India, Nov. 16, 2021 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) and Biocon Biologics Ltd. today announced the U.S. launch of interchangeable biosimilars SEMGLEE ® (insulin glargine-yfgn) injection, a branded product, and Insulin Glargine (insulin glargine-yfgn) injection, an unbranded product, …

  • biocon.com
    Diversity And Inclusion one of our biggest assets at Biocon

    https://www.biocon.com/careers/diversity-and-inclusion/

    One of our biggest assets. Diverse experiences and perspectives create a culture of innovation, to overcome the world’s healthcare challenges. We are committed to embracing diversity and inclusion in everything we do. It is beyond promoting gender balance. It is about the appreciation of different cultures, backgrounds, generations and ideas ...

  • biocon.com
    Learning & Development - Biocon - Global Biopharmaceutical …

    https://www.biocon.com/careers/learning-development/

    At Biocon, constant learning is a way of life across every department and at every level. It aligns individual success with the organisation’s current and future growth. Our Learning Framework is built around technical capability-building, our competency framework and the Biocon values. We offer a wide range of programs to provide ...

  • biocon.com
    Biocon Ranked No. 8 Among Science Magazine’s Best …

    https://www.biocon.com/biocon-ranked-no-8-among-science-magazines-best-employers-in-global-biotech-and-pharma-sector/

    Bengaluru, Karnataka, India: October 31, 2023: Biocon Limited (BSE code: 532523, NSE: BIOCON), an innovation-led global biopharmaceuticals company, today announced it has once again solidified its standing as a premier employer by retaining its position amongst the Top 10 Employers in the global biotech, pharma and biopharma …

  • sciencedirect.com
    Biological Conservation | Journal | ScienceDirect.com by Elsevier

    https://www.sciencedirect.com/journal/biological-conservation

    Biological Conservation is a leading international journal in the discipline of conservation science.The journal publishes articles spanning a diverse range of fields that contribute …

  • bioconbiologicseu.com
    Biocon Biologics | Advancing Biosimilars for a Healthier and …

    https://www.bioconbiologicseu.com/

    Biocon Biologics is a leading global player in the development, manufacturing and commercialization of biosimilars. Our cutting-edge science, extensive portfolio of biosimilars, and commitment to quality and compliance make us a trusted choice for healthcare providers and patients worldwide. Discover how we're advancing biosimilars to save …

  • biocon.com
    Siddharth Mittal - CEO and Managing Director - Biocon

    https://www.biocon.com/about-us/management-team/siddharth-mittal-biocon/

    Mr. Siddharth Mittal is Managing Director and CEO of Biocon Limited. He joined the company in May 2013 and served as President & Chief Financial Officer until November 2019. With diverse global experience in strategic finance and accounting, mergers and acquisitions and general management, Siddharth has assumed positions of increasing ...

  • biocon.com
    Kiran Mazumdar-Shaw - Executive Chairperson - Biocon

    https://www.biocon.com/about-us/board-of-directors-biocon/kiran-mazumdar-shaw-biocon/

    Executive Chairperson – Biocon Limited and Biocon Biologics Limited. Kiran Mazumdar-Shaw is a first-generation entrepreneur and global business leader with over 4 decades of experience in biotechnology. Fueled by her passion, she started her biotech journey in 1978 from her garage in India. Today, that journey is changing lives for the better ...

  • biocon.com
    Sustainability - Biocon - Global Biopharmaceutical company

    https://www.biocon.com/responsibility/sustainability/

    SUSTAINABILITY. Sustainable development is an integral part of Biocon’s business strategy. We are increasingly converging our activities to provide a rewarding workplace, be a responsible partner and create value in communities. Our aim is to achieve sustainable growth through positive social and environmental impacts.

  • business-standard.com
    Biocon Ltd soars 2.25%, up for fifth straight session

    https://www.business-standard.com/markets/capital-market-news/biocon-ltd-soars-2-25-up-for-fifth-straight-session-124061100434_1.html

    Biocon Ltd gained for a fifth straight session today. The stock is quoting at Rs 347.55, up 2.25% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up …

  • biocon.com
    Generic Formulations - Biocon - Global Biopharmaceutical company

    https://www.biocon.com/businesses/generics/generic-formulations/

    The strength of our generic formulations business is powered by our portfolio of complex and differentiated APIs. Forward integration into dosage forms fulfils our commitment to provide continuity of supply of affordable quality medicines to patients across geographies. At Biocon, we have commenced multiple programs to build a robust pipeline ...

  • bioconbiologics.com
    About Us - Biocon Biologics

    https://www.bioconbiologics.com/about-us/

    As a responsible corporate citizen, we have designed our operations to enable environmental sustainability with a low carbon footprint while ensuring maximum …

  • biocon.com
    Biocon Limited announces the acquisition of a manufacturing …

    https://www.biocon.com/biocon-limited-announces-the-acquisition-of-a-manufacturing-facility-of-eywa-pharma-inc/

    September- 01, 2023. Biocon Limited (BSE code: 532523, NSE: BIOCON), an innovation-led global biopharmaceutical company, today announced that its step-down, wholly-owned subsidiary, Biocon Generics Inc., has acquired Eywa Pharma Inc.’s oral solid dosage manufacturing facility, located in Cranbury, New Jersey, U.S., effective 1 st September, …

  • bioconapi.com
    Biocon Portal

    https://www.bioconapi.com/

    Biocon’s global portfolio in Active Pharmaceutical Ingredient (API) caters to over 400+ pharma companies in 100+ countries including the U.S, Europe and emerging markets, …

  • biocon.com
    Press Releases, Company Statements, Media Stories - Biocon

    https://www.biocon.com/news-biocon/

    News. Biocon / News. We recognise that regular, effective, balanced and timely communication is important to help us maintain our credibility as a publicly listed company. In this section we provide company information related to quarterly earnings, key achievements, regulatory approvals, recognitions & felicitations, business profiles and ...

See More

DNS Lookup

DNS entries, such as A, NS, MX, and TXT records, are crucial for the functioning of the Internet. The A record maps a domain name to an IPv4 address, while the NS record specifies authoritative name servers for a domain. The MX record identifies the mail server responsible for receiving email messages for a domain. Additionally, the TXT record allows for the association of any text information with a domain name. These records play a vital role in ensuring proper communication and connectivity across the internet.

HostClassTTLTypeData
biocon.comIN300Aip: 104.211.200.148
biocon.comIN86400NStarget: hera.ns.cloudflare.com
biocon.comIN86400NStarget: kai.ns.cloudflare.com
biocon.comIN1800SOAmname: hera.ns.cloudflare.comrname: dns.cloudflare.comserial: 2341742335refresh: 10000retry: 2400expire: 604800minimum-ttl: 1800
biocon.comIN300MXtarget: mx2.hc432.c3s2.iphmx.compri: 5
biocon.comIN300MXtarget: mx1.hc432.c3s2.iphmx.com
biocon.comIN300TXTtxt: v=spf1 include:spf.protection.outlook.com ip4:68.232.151.131 ip4:68.232.159.85 ip4:123.63.251.208 ip4:121.244.94.4 ip4:121.244.95.65 ip4:123.63.251.193 ip4:121.244.94.1 ip4:121.244.94.9 ip4:123.63.251.194 ip4:123.63.251.195 ip4:121.244.94.19 ip4:121.244.94.11 ip4:216.71.139.40 ip4:216.71.159.190 exists:%{i}.spf.hc432.c3s2.iphmx.com -all
biocon.comIN300TXTtxt: google-site-verification=M7wdgOzDfrcg6DIvvLhl79RQUYhiKkkkCq8mTTamouM
biocon.comIN300TXTtxt: _globalsign-domain-verification=BLZ4LV9maYEq4RcjoiSExxzbrHn8y4x43ItZJi2GVZ
biocon.comIN300TXTtxt: _globalsign-domain-verification=n0BPk-PLWzQf-XOT8u0tZT2f4EedOx-3IIYL2pnKRP
biocon.comIN300TXTtxt: _globalsign-domain-verification=C6KUX7G2mI1YZ_qqCmeaS2bUVHhF6_htg6RJN_QQaQ
biocon.comIN300TXTtxt: MS=ms82044672
biocon.comIN300TXTtxt: _globalsign-domain-verification=juJ4-sfIi6iau5xRtWrmj6BxHOFWuzoKh6tvmUahjH
biocon.comIN300TXTtxt: duo_sso_verification=JXO3QLYKzb7ZhcK7cVgPIDk2A8k965uXWNfnSont9nXHMtVVtLTuVa8BemijgO6w
biocon.comIN300TXTtxt: edcf89b1-a4ff-4b4d-a68c-63589b56ad70
biocon.comIN300TXTtxt: v=DKIM1; p=MIIBIjANBgkqhkiG9w0BAQEFAAOCAQ8AMIIBCgKCAQEAmDyNd5i5KVq/gJS5bnpHgyRTECgV+6uMUETbaDffyew8658SIwJZfxti8rHnCulQsAyFo53iaKUph+Y0cA0NziX8XZFuZzyJbpOnSBX6l5XdyDrRhDgw0qKy70YjCm9YZU5G5K1VuaWEVNQp8QkIjpFkpTeshzKvL5dTz4e0JwNSgg8rWKfzpurSrq3ZVsE6bpWx/bFe a2tqiyHp8rXhX88q3UqxdulA74vgH1+ytGRsUerp4vB7V55Vij1gnqhhqspHwXLOuH9R/1HBMDBjaKuXzEaJ67v9hsgPrzsRUYAyyo7l6pVNWlo1idXHtTfRLlXDUePMRsstL6UjPLoH2wIDAQAB;
biocon.comIN300TXTtxt: c03lEetK6ZdxxgkyiVzFfWGOOezNs0yZrl6DAv3gGdo=
biocon.comIN300TXTtxt: google-site-verification=8FrqZEhQm8QaFjjEsBMl4JBwEMbG3fZtberm8rrW8cI
biocon.comIN300TXTtxt: _globalsign-domain-verification=KSfjOM3wVTFC0T5sUV-fSTE7k2flrr81pszARVtRU9
biocon.comIN300TXTtxt: oCE07GnI04LzsW/4HO4ffJCdzvLUkHzqA1OF2aQ64TrAdbJPKtQ0gqI8z1AEmBRr0qw6bMybfaPTWNUMBWFP8Q==
biocon.comIN300TXTtxt: google-site-verification=FJ8qLUMg8pgL8fqhjoCI8_jr54q7xLCBikiRhzE-hFc

biocon.com Traffic Analysis

According to global rankings, biocon.com holds the position of #359511. It attracts an approximate daily audience of 3.43K visitors, leading to a total of 3546 pageviews. On a monthly basis, the website garners around 102.99K visitors.

Daily Visitors3.43K
Monthly Visits102.99K
Pages per Visit4.76
Visit Duration0:03:82
Bounce Rate44.19%
Want complete report?Full SEMrush Report >>
Daily Unique Visitors:
3433
Monthly Visits:
102993
Pages per Visit:
4.76
Daily Pageviews:
3546
Avg. visit duration:
0:03:82
Bounce rate:
44.19%
Monthly Visits (SEMrush):
105449

Traffic Sources

SourcesTraffic Share
Social:
0.53%
Paid Referrals:
1.97%
Mail:
0.00%
Search:
53.98%
Direct:
43.51%

Visitors by Country

CountryTraffic Share
India:
66.35%
Malaysia:
12.41%
United States:
7.36%
United Kingdom:
4.03%
Singapore:
3.79%

SSL Checker - SSL Certificate Verify

An SSL certificate is a digital certificate that ensures a secure encrypted connection between a web server and a user's browser. It provides authentication and encryption to keep data private and protected during transmission. biocon.com supports HTTPS, demonstrating their commitment to providing a secure browsing experience for users.

name
/C=IN/ST=Karnataka/L=Bengaluru/O=BIOCON LIMITED*.biocon.com
hash
2d3d2f01
issuer
GlobalSign nv-sa
version
2
serialNumber
29992534885188836586802889939
validFrom_time_t
1688638862
validTo_time_t
1722939661
signatureTypeSN
RSA-SHA256
signatureTypeLN
sha256WithRSAEncryption
signatureTypeNID
668
keyUsage
Digital Signature, Key Encipherment
extendedKeyUsage
TLS Web Server Authentication, TLS Web Client Authentication
basicConstraints
CA:FALSE
subjectKeyIdentifier
AE:29:D1:B8:AF:56:D7:75:DF:AD:55:20:B7:42:E4:8D:27:73:06:CC
authorityKeyIdentifier
keyid:F8:EF:7F:F2:CD:78:67:A8:DE:6F:8F:24:8D:88:F1:87:03:02:B3:EB
authorityInfoAccess
CA Issuers - URI:http://secure.globalsign.com/cacert/gsrsaovsslca2018.crt OCSP - URI:http://ocsp.globalsign.com/gsrsaovsslca2018
subjectAltName
DNS:*.biocon.com, DNS:biocon.com
certificatePolicies
Policy: 1.3.6.1.4.1.4146.1.20 CPS: https://www.globalsign.com/repository/ Policy: 2.23.140.1.2.2

HTTP Headers

HTTP headers are additional segments of data exchanged between a client (e.g. a web browser) and a server during an HTTP request or response. They serve to provide instructions, metadata, or control parameters for the interaction between the client and server.

Status
HTTP/1.1 301 Moved Permanently
Date
Tue, 28 May 2024 08:47:27 GMT
Server
Apache/2.4.18 (Ubuntu)
Strict-Transport-Security
max-age=63072000; includeSubdomains; preload
X-XSS-Protection
1; mode=block
X-Content-Type-Options
nosniff
X-Frame-Options
DENY
Expires
Tue, 28 May 2024 09:47:27 GMT
Cache-Control
max-age=3600
X-Redirect-By
WordPress
Location
https://www.biocon.com/
Strict-Transport-Security
max-age=31536000; includeSubDomains; preload
Content-Type
text/html; charset=UTF-8
Status
HTTP/1.1 200 OK
Date
Tue, 28 May 2024 08:47:28 GMT
Server
Apache/2.4.18 (Ubuntu)
Strict-Transport-Security
max-age=63072000; includeSubdomains; preload
X-XSS-Protection
1; mode=block
X-Content-Type-Options
nosniff
X-Frame-Options
DENY
Link
; rel="https://api.w.org/"
Link
; rel="alternate"; type="application/json"
Link
; rel=shortlink
Strict-Transport-Security
max-age=31536000; includeSubDomains; preload
Content-Type
text/html; charset=UTF-8

Where is biocon.com hosted?

biocon.com is likely hosted in various data centers located across different regions worldwide. The current data center mentioned is just one of many where the website may be hosted.

Whois Information

WHOIS protocol used to get domain/IP info. Common for reg details, ownership of a domain/IP. Check biocon.com for reg/admin contact info, owner, org, email, phone, creation, and expiration dates.

Domain Updated Date:2022-01-10
Domain Created Date:1996-03-11
Domain Expiry Date:
Domain Name:
Registrar WHOIS Server:whois.networksolutions.com
Registrar Abuse Contact Email:[email protected]
Registrar Abuse Contact Phone:+1.8777228662
Domain Registrar:Network Solutions, LLC
Domain Owner:

Domain Name: BIOCON.COM

Registry Domain ID: 872049_DOMAIN_COM-VRSN

Registrar WHOIS Server: whois.networksolutions.com

Registrar URL: http://networksolutions.com

Updated Date: 2022-01-10T05:17:46Z

Creation Date: 1996-03-11T05:00:00Z

Registry Expiry Date: 2027-03-12T05:00:00Z

Registrar: Network Solutions, LLC

Registrar IANA ID: 2

Registrar Abuse Contact Email: [email protected]

Registrar Abuse Contact Phone: +1.8777228662

Name Server: KAI.NS.CLOUDFLARE.COM

SEO Analysis

SEO analysis involves examining the performance of a website, including titles, descriptions, keywords, and website speed. It also includes identifying popular keywords and researching competitor websites to understand their strategies. The analysis aims to optimize the website's visibility and improve its ranking on search engines.

Title Tag:
Biocon - India's largest biopharmaceutical company

Length: 50 characters

Title tags are usually best kept short, within 50-70 characters. It's important to note that search engines will typically read the entire title tag even if it exceeds 70 characters, but there is a chance they may cut it off or disregard it.

Meta Description:
Biocon is an innovation led fully integrated biopharmaceutical company that develop affordable biosimilars, generic formulations & complex APIs

Length: 143 characters

When crafting website descriptions, keep in mind that search engines only show the first 150-160 characters in search results. To ensure your entire description is visible, aim for a length of 25-160 characters. If your description is too long, it may get cut off. Conversely, if it's too short, search engines may add text from elsewhere on your page. Additionally, search engines may modify the description you provide to better match the user's search intent. It's best to strike a balance between brevity and relevance for optimal visibility.

Meta Keywords:

No meta keywords found.

In the realm of search engine optimization, the meta keywords tag has become a relic of the past due to its potential for misuse, ultimately leading major search engines to disregard it in their ranking algorithms.

Keywords Cloud:
Term Count Density
biocon 32 5.34%
biologics 12 2.00%
overview 8 1.34%
research 6 1.00%
global 6 1.00%

A crucial factor in search engine optimization is keyword density, which refers to the proportion of a particular keyword present in the text of a webpage. In order to achieve high rankings on search engine results pages, it is essential to maintain the appropriate keyword density for your primary keyword.

Headings:
<H1>
1
<H2>
8
<H3>
3
<H4>
4
<H5>
2
<H6>
0
<h1>Driven by purpose.</h1>
<h2> INTEGRATED ANNUAL REPORT 2023 </h2>
<h2>WHO WE ARE</h2>
<h2>RESPONSIBILITY</h2>
<h2>NEWS</h2>
<h2> GOVERNANCE </h2>
<h2> BRSR, GRI & ESG DATA BOOK - 2023 </h2>
<h2>Driven by purpose.</h2>
<h2>GLOBAL PRESENCE</h2>
<h3>RESPONSIBILITY</h3>
<h3>WHO WE ARE</h3>
<h3>OUR BUSINESSES</h3>
<h4>Get in Touch</h4>
<h4>Recommended Sites</h4>
<h4>Quick Links</h4>
<h4>Businesses</h4>
<h5> Agree </h5>
<h5>Leaving the Biocon site!</h5>

In SEO, the primary focus is placed on keywords within the content. The title of the page holds the highest importance, followed by heading tags such as h1, h2, and h3. The h1 heading should be the largest on the page, while the h2 heading should be slightly smaller, and the h3 heading even smaller. This hierarchical structure is crucial for optimizing search engine rankings.

Image Alt Attribute:
76 images found in your page, and 58 images are without "ALT" text.

What is the issue about?
The tag does not have an ALT attribute defined. As a general rule, search engines do not interpret the content of image files. The text provided in the attribute enables the site owner to provide relevant information to the search engine and to the end user. Alt text is helpful to end users if they have images disabled or if the image does not properly load. In addition, the Alt text is utilized by screen readers. Make sure that your Alt text is descriptive and accurately reflects what the image represents and supports the content on the page.

How to fix?
Use the <img alt> attribute to write descriptive content for the image: <img source='pic.gif' alt='Accurate and descriptive keyword text that represents the image.' />.

Website Speed Test (Desktop):
0.21 seconds

Website speed is a measurement of how fast the content on your page loads. Website speed is one of many factors involved in the discipline of search engine optimization (SEO), but it is not the only one. In a recent study, the average load time for a web page was 3.21s.

Top Organic Search Terms:
Term Search Volume Traffic Traffic (%)
https biospace biocon com 2400 1 0%
biospace biocon com 6600 1 0%
biocon biospace 5400 0 0%
https biospace biocon com login 110 0 0%
bio space biocon com 140 0 0%
htpps biospace biocon com 170 0 0%
biospace biocon 18100 0 0%
www biospace biocon 320 0 0%
biocon biospace login 390 0 0%

CO-Hosted

CoHosted refers to a situation where multiple domain names (websites) are using the same IP address to point to their respective web servers. They could be owned by different individuals or organizations and may serve entirely different purposes.

biocon.com

People reviews about biocon.com

Very positive reviews

rating 5

Total reviews: 2
Average score: 5 stars

The total score is based on reviews found on the following sites
Scamadviser: 5/5 stars, 2 reviews

Add your review

rating 1 rating 2 rating 3 rating 4 rating 5

Very positive reviews

rating 5

Total reviews: 2
Average score: 5 stars

The total score is based on reviews found on the following sites
Scamadviser: 5/5 stars, 2 reviews


Back Top
Feedback